Carrie L. Byington, M.D.

Research Interests

  • Streptococcus pneumoniae
  • Infectious Disease

Languages

  • English
  • Spanish

Academic Information

  • Departments: Pediatrics - Professor
  • Divisions: General Pediatrics

Board Certification

  • American Board of Pediatrics (Sub: Pediatric Infectious Diseases)
  • American Board of Pediatrics (Pediatrics)

Academic Office Information

  • (801) 585-5282
  • Health Sciences Education Building
    26 South 2000 East, Room: 5515
    Salt Lake City, UT 84112

Academic Bio

Dr. Byington's research focuses on viral and bacterial infections in infants and children. Research has included the development of new diagnostics, the clinical validation of diagnostics, epidemiology of infectious diseases using molecular diagnostics, and improving health services, including public health, through accurate diagnostics and informatics. The primary pathogens studied include enteroviruses, respiratory viruses particularly influenza and bacterial pathogens including Streptococcus pneumoniae and Neisseria meningitidis. Dr. Byington has several active NIH and CDC grants that support her work. She mentor undergraduates, medical students, residents, fellows and junior faculty conducting clinical and translational research. She is the Director of several Career Development Programs in Pediatrics. She has mentored over 90 trainees and junior faculty, the majority women and under-represented minorities.

Education History

Type School Degree
Certification Univeristy of Utah
Conflict Mediation
Certificate
Fellowship Univ of California, San Francisco
Pediatric Infectious Diseases
Fellow
Chief Resident Baylor College of Medicine
Neonatology
Chief Resident
Residency Baylor College of Medicine
Pediatrics
Resident
Internship Baylor College of Medicine
Pediatrics
Intern
Professional Medical Baylor College of Medicine
Medicine
M.D.
Undergraduate Texas A&M University
B.S.

Selected Publications

Journal Article

  1. Byington C, Keenan H, Phillips JD, Childs R, Wachs E, Berzins MA, Clark K, Torres MK, Abramson J, Lee V, Clark EB (In Press). A matrix mentoring model effectively supports clinical and translational scientists and increases inclusion in biomedical research. Acad Med.
  2. Respiratory syncytial virus-associated mortality in hospitalized infants and young children.Byington CL, Wilkes J, Korgenski K, Sheng X (2015). Respiratory syncytial virus-associated mortality in hospitalized infants and young children. Pediatrics, 135(1), e24-31.
  3. Vaccines: can transparency increase confidence and reduce hesitancy?Byington CL (2014). Vaccines: can transparency increase confidence and reduce hesitancy? Pediatrics, 134(2), 377-9.
  4. The CTSA mentored career development program: supporting the careers of child health investigators.Byington CL, Higgins S, Kaskel FJ, Purucker M, Davis JM, Smoyer WE (2014). The CTSA mentored career development program: supporting the careers of child health investigators. Clin Transl Sci, 7(1), 44-7.
  5. Dipstick screening for urinary tract infection in febrile infants.Glissmeyer EW, Korgenski EK, Wilkes J, Schunk JE, Sheng X, Blaschke AJ, Byington CL (2014). Dipstick screening for urinary tract infection in febrile infants. Pediatrics, 133(5), e1121-7.
  6. Developing future clinician scientists while supporting a research infrastructure.Holsti M, Adelgais KM, Willis L, Jacobsen K, Clark EB, Byington CL (2013). Developing future clinician scientists while supporting a research infrastructure. Clin Transl Sci, 6(2), 94-7.
  7. Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah.Stockmann C, Ampofo K, Byington CL, Filloux F, Hersh AL, Blaschke AJ, Cowan P, Korgenski K, Mason EO, Pavia AT (2013). Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics, 132(3), 421-8.
  8. Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era.Kendall BA, Dascomb KK, Mehta RR, Mason EO, Ampofo K, Pombo DJ, Pavia AT, Byington CL (2011). Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era. Vaccine, 29(49), 9123-6.
  9. Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era.Ampofo K, Pavia AT, Stockmann CR, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Byington CL (2011). Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era. Pediatr Infect Dis J, 30(12), 1100-3.
  10. The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Children's Hospital through the PCV7 Era.Ampofo K, Pavia AT, Stockmann C, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL (2011). The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Children's Hospital through the PCV7 Era. (Epub ahead of print) Pediatr Infect Dis J.
  11. Non-invasive sample collection for respiratory virus testing by multiplex PCR.Blaschke AJ, Allison MA, Meyers L, Rogatcheva M, Heyrend C, Mallin B, Carter M, Lafleur B, Barney T, Poritz MA, Daly JA, Byington CL (2011). Non-invasive sample collection for respiratory virus testing by multiplex PCR. J Clin Virol, 52(3), 210-4.
  12. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH Jr, Moore MR, St Peter SD, Stockwell JA, Swanson JT, Pediatric Infectious Diseases Society and the Infectious Diseases Society of America (2011). The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis, 53(7), e25-76.
  13. American Academy of Pediatrics, Committee on Infectious Diseases (In Press). Recommendations for prevention and control of influenza in children 2011-2012. Pediatrics.
  14. Management of the non-toxic-appearing acutely febrile child: a 21st century approach.Jhaveri R, Byington CL, Klein JO, Shapiro ED (2011). Management of the non-toxic-appearing acutely febrile child: a 21st century approach. J Pediatr, 159(2), 181-5.
  15. Baker C, and Byington CL and American Academy of Pediatrics, Committee on Infectious Diseases (In Press). Recommendation for the prevention of perinatal Group B streptococcal disease. Pediatrics.
  16. Policy statement--recommended childhood and adolescent immunization schedules--United States, 2011. (2011). Policy statement--recommended childhood and adolescent immunization schedules--United States, 2011. Pediatrics, 127(2), 387-8.
  17. Byington CL, Kendrick J, Sheng X (2011). Normative cerebrospinal fluid profiles in febrile infants. J Pediatr, 158(1), 33-37.
  18. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema.Blaschke AJ, Heyrend C, Byington CL, Obando I, Vazquez-Barba I, Doby EH, Korgenski EK, Sheng X, Poritz MA, Daly JA, Mason EO, Pavia AT, Ampofo K (2011). Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J, 30(4), 289-94.
  19. Bernstein HH, Starke JR, Committee on Infectious Diseases (2010). Recommendation for mandatory influenza immunization of all health care personnel. Pediatrics, 126(4), 809-15.
  20. Ampofo, K, Herbener, A, Blaschke, AJ, Heyrend, C, Portiz, M, Korgenski, K, Rolfs, R, Jain, S, Carvahlo, MD, Pimenta, FC, Daly, J, Mason, EO, Byington, CL (2010). Association of 2009 Pandemic Influenza A (H1N1) infection and increased hospitalization with Parapneumonic Empyema in Children in Utah. Pediatr Infect Dis, (10), 905-9.

News

Video